Clinical Report: Antibiotic precedes auto-brewery relapse
Overview
A man in his mid-40s with known auto-brewery syndrome (ABS) developed severe endogenous ethanol intoxication five days after starting amoxicillin/clavulanate for community-acquired pneumonia, following approximately two years without symptoms. He recovered within hours with supportive care after the antibiotic was discontinued. The case authors considered antibiotic-associated microbiome disruption a possible contributor but emphasized that a single case cannot establish causation.
Background
ABS is characterized by endogenous ethanol production associated with gastrointestinal microorganisms and can present as apparent alcohol intoxication despite reported abstinence. The patient’s earlier evaluation identified small intestinal bacterial overgrowth and increased Proteobacteria, predominantly Enterobacter species; a 14-day course of rifaximin and probiotics was followed by an approximately two-year asymptomatic period. The authors noted that ABS has been associated with ethanol-producing yeasts, while bacteria may also contribute to ethanol production. They cited prior case reports in which antibiotic exposure preceded symptoms in 7 of 16 cases, but the evidence does not establish a causal relationship.
Data Highlights
| Measure or clinical detail | Finding |
|---|---|
| Age and setting | Man in his mid-40s; emergency department in Switzerland, early 2025 |
| Recent antibiotic exposure | Amoxicillin/clavulanate started 5 days before presentation for community-acquired pneumonia |
| ABS symptom-free interval | Approximately 2 years after rifaximin and probiotics |
| Presentation | Glasgow Coma Scale score 9; blood alcohol concentration 43.6 mmol/L despite reported abstinence |
| Earlier episode | Blood alcohol concentration 46.8 mmol/L approximately 2 months after inpatient psychiatric rehabilitation in 2020 |
| Prior microbiology | Small intestinal bacterial overgrowth and increased Proteobacteria, predominantly Enterobacter species; Klebsiella species were not detected |
| Prior case reports cited | Antibiotic exposure preceded symptoms in 7 of 16 ABS cases |
| Outcome | Recovered within hours after rehydration and supportive care; discharged with Glasgow Coma Scale score 15 and no neurologic deficits |
Key Findings
- The patient was found unresponsive five days after beginning amoxicillin/clavulanate and had a Glasgow Coma Scale score of 9 and blood alcohol concentration of 43.6 mmol/L despite reported abstinence, confirmed by his partner.
- Arterial blood gas results were within normal limits, cranial computed tomography showed no intracranial hemorrhage or structural brain damage, and empiric naloxone and flumazenil produced no clinical improvement.
- Amoxicillin/clavulanate was discontinued; after rehydration and supportive intensive care, the patient recovered within hours and was discharged without neurologic deficits.
- Earlier evaluation in 2023 identified small intestinal bacterial overgrowth and increased Proteobacteria, predominantly Enterobacter species. Rifaximin and probiotics were followed by approximately two years without ABS symptoms.
- The investigators proposed that antibiotic-associated dysbiosis may have contributed to recurrence, while noting that the temporal association in this single-patient report cannot establish that amoxicillin/clavulanate caused it.
- The authors cited prior case reports in which antibiotic exposure preceded symptoms in 7 of 16 ABS cases and stated that ABS should be considered in otherwise unexplained intoxication when reported abstinence is credible; they advised caution with antibiotic therapy in patients with known ABS.
Clinical Implications
The authors state that ABS should be considered when alcohol intoxication is otherwise unexplained and reported abstinence is credible. For patients with known ABS, they advise approaching antibiotic therapy with caution, while recognizing that this case does not establish antibiotic causation and that the patient’s prior alcohol overuse and gastrointestinal findings complicate interpretation.
Conclusion
This case describes ABS recurrence after recent amoxicillin/clavulanate exposure following a prolonged symptom-free interval. Antibiotic-associated dysbiosis is a proposed explanation, not a demonstrated cause.
Related Resources & Content
- Widmer et al., Oxford Medical Case Reports, 2026 — Co-amoxicillin–induced reactivation of auto-brewery syndrome in a patient treated for community acquired pneumonia: a clinical case report
- StatPearls, NCBI Bookshelf, year not specified — Auto-Brewery Syndrome
- Nature Microbiology, 2026 — Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort
- the medicine maker — Treating Before Infection?
- the medicine maker — Antibiotic Apocalypse: Part II
- the medicine maker — Down with the Resistance
- ASCO Publications — Antibiotic cycling to decrease bacterial antibiotic resistance: A 7-year experience on a bone marrow transplant unit
- Co-amoxicillin–induced reactivation of auto-brewery syndrome in a patient treated for community acquired pneumonia: a clinical case report
- Auto-Brewery Syndrome - StatPearls
- Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort
- Auto-Brewery Syndrome - StatPearls - NCBI Bookshelf
- Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort | Nature Microbiology
- Co-amoxicillin–induced reactivation of auto-brewery syndrome in a patient treated for community acquired pneumonia: a clinical case report | Oxford Medical Case Reports | Oxford Academic
- Auto-brewery Syndrome Presenting with Recurrent Episodes of Reduced Level of Consciousness, Confusion, and Ataxia (P12-5.030) | Neurology
- Auto-Brewery Syndrome: Symptoms, Causes & Treatment
Based on findings from:
Antibiotic precedes auto-brewery relapse
Andrea Surnit. MDSpire News, 2026.
https://news.mdspire.com/internal-medicine/articles/amoxicillinclavulanate-may-trigger-abs-relapse/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.